Skip navigation

Calls to Action

Clinical Trials

December 31, 2015

European Medicines Agency provides guidance on selecting study participants and assessing effectiveness of new autism treatments

April 10, 2012

Autism Speaks is pleased to announce the publication of its Participant’s Guide to Autism Drug Research.

October 13, 2011

Autism Speaks has named Joseph Patrick Horrigan, M.D., FAACAP to the newly created position of assistant vice president, head of medica

April 17, 2008

Neuropharm Group plc, sponsor of the Study of Fluoxetine in Autism (SOFIA) clinical trial, received "Fast Track" designation